Sfoglia per Rivista CANCER CHEMOTHERAPY AND PHARMACOLOGY
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastroesophageal junction adenocarcinoma
2010-01-01 Loupakis, F.; Masi, G.; Fornaro, L.; Vasile, E.; Allegrini, G.; Fontana, E.; Granetto, C.; Salvatore, L.; Mentuccia, L.; Andreuccetti, M.; Cortesi, E.; Merlano, M.; Cascinu, S.; Falcone, Alfredo
Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
2012-01-01 Petrini, Iacopo; Lencioni, M; Ricasoli, M; Iannopollo, M; Orlandini, C; Oliveri, F; Bartolozzi, Carlo; Ricci, S.
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro
2018-01-01 Citi, Valentina; Del Re, Marzia; Martelli, Alma; Calderone, Vincenzo; Breschi, Maria Cristina; Danesi, Romano
Pro-apoptotic and cytostatic activity of naturally occurring cardenolides
2009-01-01 E., Bloise; Braca, Alessandra; N., DE TOMMASI; M. A., Belisario
Protective effects of fructose-1,6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats
1990-01-01 Danesi, Romano; Bernardini, Nunzia; Marchetti, A; Bernardini, M; DEL TACCA, M.
Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study
1999-01-01 Falcone, Alfredo; Allegrini, G.; Lencioni, M.; Pfanner, E.; Brunetti, I.; Cianci, C.; Galli, C.; Masi, G.; Antonuzzo, A.; Conte, P. F.
REDUCED CARDIOTOXICITY AND INCREASED CYTOTOXICITY IN A NOVEL ANTHRACYCLINE ANALOG, 4'-AMINO-3'-HYDROXY-DOXORUBICIN
1992-01-01 Danesi, Romano; Bernardini, Nunzia; Agen, C; Costa, M; Zaccaro, L; Pieracci, D; Malvaldi, G; DEL TACCA, M.
REDUCING DOXORUBICIN CARDIOTOXICITY IN THE RAT USING DEFERRED TREATMENT WITH ADR-529
1992-01-01 Agen, C; Bernardini, Nunzia; Danesi, Romano; Dellatorre, P; Costa, M; Deltacca, M.
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
2012-01-01 Grossi, F; Rijavec, E; Dal Bello, Mg; Defferrari, C; Brianti, A; Barletta, G; Genova, C; Murolo, C; Cosso, M; Fontanini, Gabriella; Boldrini, Laura; Truini, M; Pronzato, P. Cancer Chemother P. h. a. r. m. a. c. o. l. 2012 Feb 2. 1.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastroesophageal junction adenocarcinoma | 1-gen-2010 | Loupakis, F.; Masi, G.; Fornaro, L.; Vasile, E.; Allegrini, G.; Fontana, E.; Granetto, C.; Salvatore, L.; Mentuccia, L.; Andreuccetti, M.; Cortesi, E.; Merlano, M.; Cascinu, S.; Falcone, Alfredo | |
| Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma | 1-gen-2012 | Petrini, Iacopo; Lencioni, M; Ricasoli, M; Iannopollo, M; Orlandini, C; Oliveri, F; Bartolozzi, Carlo; Ricci, S. | |
| Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro | 1-gen-2018 | Citi, Valentina; Del Re, Marzia; Martelli, Alma; Calderone, Vincenzo; Breschi, Maria Cristina; Danesi, Romano | |
| Pro-apoptotic and cytostatic activity of naturally occurring cardenolides | 1-gen-2009 | E., Bloise; Braca, Alessandra; N., DE TOMMASI; M. A., Belisario | |
| Protective effects of fructose-1,6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats | 1-gen-1990 | Danesi, Romano; Bernardini, Nunzia; Marchetti, A; Bernardini, M; DEL TACCA, M. | |
| Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study | 1-gen-1999 | Falcone, Alfredo; Allegrini, G.; Lencioni, M.; Pfanner, E.; Brunetti, I.; Cianci, C.; Galli, C.; Masi, G.; Antonuzzo, A.; Conte, P. F. | |
| REDUCED CARDIOTOXICITY AND INCREASED CYTOTOXICITY IN A NOVEL ANTHRACYCLINE ANALOG, 4'-AMINO-3'-HYDROXY-DOXORUBICIN | 1-gen-1992 | Danesi, Romano; Bernardini, Nunzia; Agen, C; Costa, M; Zaccaro, L; Pieracci, D; Malvaldi, G; DEL TACCA, M. | |
| REDUCING DOXORUBICIN CARDIOTOXICITY IN THE RAT USING DEFERRED TREATMENT WITH ADR-529 | 1-gen-1992 | Agen, C; Bernardini, Nunzia; Danesi, Romano; Dellatorre, P; Costa, M; Deltacca, M. | |
| The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib | 1-gen-2012 | Grossi, F; Rijavec, E; Dal Bello, Mg; Defferrari, C; Brianti, A; Barletta, G; Genova, C; Murolo, C; Cosso, M; Fontanini, Gabriella; Boldrini, Laura; Truini, M; Pronzato, P. Cancer Chemother P. h. a. r. m. a. c. o. l. 2012 Feb 2. 1. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile